Formulary for mental health medications

Size: px
Start display at page:

Download "Formulary for mental health medications"

Transcription

1 Formulary for mental health medications The Medicines Management Committee has approved this list of formulary medicines with links to national and local prescribing guidelines. If a medicine for a mental health condition (or the treatment of substance misuse) is not on this list then it is not on the Trust Formulary; pharmacy should be contacted for advice. The full formulary process is described in the CPFT Medicines Policy. Specific comments are included for medicines that are covered by: NICE Technology Appraisals CPFT prescribing guidelines CSM (Committee for Safety of Medicines) or MHRA (Medicines and Healthcare Regulatory Agency) advice in the BNF CCG prescribing restrictions The following NICE clinical guidelines contain recommendations about drug treatment of mental health conditions ( Schizophrenia in adults (CG82) March 2009 Bipolar disorder in adults, children and adolescents (CG38) July 2006 Rapid tranquillisation: disturbed/violent behaviour in psychiatric in-patient settings and emergency departments (CG25) Feb 2005 Depression in adults (CG90) and in adults with a chronic physical health problem (CG91) Oct 2009 Depression in children and young people (CG28) Sept 2005 Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults (CG113) Jan 2011 ADHD in children, young people and adults (CG72) Sept 2008 Dementia (CG42) March 2011 Opioid detoxification (CG52) July 2007 Alcohol-related physical complications (CG100) June 2010 Harmful drinking and alcohol dependence (CG115) Feb 2011 Antisocial personality disorder (CG77) Jan 2009 Borderline personality disorder (CG78) Jan 2009 Antenatal and postnatal mental health (CG45) April 2007 Obsessive-compulsive disorder and body dysmorphic disorder (CG31) Nov 2005 PTSD in adults and children (CG26) April 2005 Eating disorders (CG9) April 2004 Smoking cessation services (PH10) Aug 2008 Autism in adults (CG142) June 2012 Psychosis and schizophrenia in children and young people Jan

2 Medicine (alphabetical order within BNF sections) Hypnotics BNF Cloral betaine Melatonin (Children s services only) Comments NICE TA77: z drugs in the short-term management of insomnia CPFT D&T minutes of CSM advice in the BNF about the prescribing of benzodiazepines. Third-line Off-label use of a licensed medicine; or unlicensed medicine* Nitrazepam Third-line Promethazine Temazepam First-line Zopiclone If temazepam is not considered suitable Anxiolytics mostly BNF CSM advice in the BNF about the prescribing of benzodiazepines CPFT Rapid tranquillisation guidelines Buspirone Clonazepam (BNF 4.8.2) Off-label use of a licensed medicine * Diazepam Lorazepam Midazolam (BNF ) Oxazepam Pregabalin (BNF 4.8.1) Promethazine (BNF 4.1.1) Antipsychotics BNF First-generation antipsychotics Chlorpromazine Flupentixol Fluphenazine Haloperidol Levomepromazine Sulpiride Trifluoperazine Zuclopenthixol (including Acuphase) Second-generation antipsychotics Amisulpride Aripiprazole (including short-acting IM injection) Clozapine Olanzapine (including short-acting IM injection) Quetiapine Alternative for rapid tranquillisation while IM lorazepam unavailable Only for second- or third-line use in GAD when SSRIs/venlafaxine not tolerated or not effective of a specialist Advice in the BNF about prescribing doses above BNF upper limit Advice in the BNF about prescribing antipsychotics in the elderly especially with dementia CPFT Rapid tranquillisation guidelines NICE TA213: Aripiprazole for the treatment of schizophreniain people aged years CSM advice in the BNF about the risk of myocarditis and cardiomyopathy with clozapine CPFT Clozapine prescribing guidelines Secondary Care (hospital) only prescribing 2

3 Risperidone Long-acting antipsychotic injections (depots) BNF Flupentixol decanoate Fluphenazine decanoate Haloperidol decanoate Paliperidone palmitate injection Paliperidone tablets are not on the formulary Paliperidone injection is available for GP prescribing after initiation by a specialist Pipotiazine palmitate Risperidone injection is available for GP prescribing after Risperidone long-acting injection initiation by a specialist Zuclopenthixol decanoate Antimanic drugs (also used as mood stabilisers) BNF Carbamazepine Lamotrigine (BNF 4.8.1) Licensed for prevention of depressive episodes associated with bipolar disorder Lithium CPFT Lithium prescribing guidelines Semisodium valproate (Depakote) Licensed only for treatment of manic episodes associated with bipolar disorder Sodium valproate (Epilim) (BNF 4.8.1) Off-label use of a licensed medicine * Antidepressants BNF 4.3 CSM advice in the BNF about antidepressants and the risk of suicidal thoughts and behaviour (esp in young people); also risk of hyponatraemia (esp in elderly) Tricyclic and related antidepressants BNF Amitriptyline Clomipramine Dosulepin Imipramine Lofepramine Nortriptyline Trazodone Monoamine oxidase inhibitors BNF Phenelzine Tranylcypromine Moclobemide (Reversible MAOI) Selective serotonin reuptake inhibitors BNF CSM advice in the BNF about the use of SSRIs in children and adolescents Citalopram Escitalopram Fluoxetine Paroxetine Sertraline Other antidepressants BNF Duloxetine Mirtazapine Tryptophan Not for first-line use of a specialist CSM advice in the BNF about appropriate doses of paroxetine. These are not an appropriate choice for the first-line treatment of depression of a specialist 3

4 Venlafaxine CNS stimulants and other drugs for attention deficit hyperactivity disorder BNF 4.4 Atomoxetine Dexamfetamine Methylphenidate Drugs used in substance dependence BNF 4.10 Alcohol dependence Acamprosate Chlordiazepoxide Disulfiram Nicotine dependence Nicotine replacement therapy Opioid dependence Buprenorphine (including buprenorphine plus naloxone) Lofexidine Methadone Naltrexone Drugs for dementia BNF 4.11 NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for ADHD in children and adolescents Cambridgeshire Shared Care Guideline for the use of atomoxetine, methylphenidate and dexamfetamine in ADHD ( CPFT Alcohol detoxification guidelines All types of NRT are included NICE TA114: Methadone and buprenorphine for opioid dependence NICE TA115: Naltrexone for opioid dependence CPFT Opioid misuse guidelines NICE TA217: Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease Cambridgeshire Shared Care Guideline for the use of Alzheimer s drugs ( Donepezil Galantamine Memantine Rivastigmine Anticholinergic medication BNF Procyclidine Orphenadrine Trihexyphenidyl * It is accepted that other licensed medicines on this list may be used for off-label indications (see list of unlicensed uses of licensed medicines within the Medicines Policy). Non-formulary medicines Medicines that the Medicines Management Committee have classed as unsuitable for inclusion in the formulary should not usually be prescribed (or recommended to GPs for prescribing). These include: Zolpidem and zaleplon Reboxetine (removed from the formulary on safety grounds) Oral paliperidone Some newer medicines have not yet been considered for the formulary so should not usually be prescribed. These include: Olanzapine long-acting injection 4

5 Agomelatine Asenapine 5

Handy charts to help people compare the medications for mental health conditions

Handy charts to help people compare the medications for mental health conditions Handy charts Handy charts to help people compare the medications for mental health conditions Contents: 1. Acute Psychiatric Emergency 2. ADHD (Attention Deficit Hyperactivity Disorder) 3. Alcohol Dependence

More information

Disclosures Christer Allgulander

Disclosures Christer Allgulander How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan

More information

Antidepressant treatment in adults

Antidepressant treatment in adults Antidepressant treatment in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive and

More information

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT

More information

Making sense of coming off psychiatric drugs. coming off psychiatric drugs

Making sense of coming off psychiatric drugs. coming off psychiatric drugs Making sense of coming off psychiatric drugs coming off psychiatric drugs Making sense of coming off psychiatric drugs Many people would like to stop their psychiatric medication, but coming off can be

More information

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that

More information

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also

More information

Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.

Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use. Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review

More information

Chapter 4: Central nervous system

Chapter 4: Central nervous system Page 1 of 15 Menu Pharmacy Home Page Chapter 4: Central nervous system POPAM The GHT Formulary applies to the treatment of adults only Policies & Forms To search the chapter click 'Ctrl' + 'F' and type

More information

Treatment and management of depression in adults, including adults with a chronic physical health problem

Treatment and management of depression in adults, including adults with a chronic physical health problem Issue date: October 2009 Depression Treatment and management of depression in adults, including adults with a chronic physical health problem This is an update of NICE clinical guideline 23 Developed by

More information

Anxiety Disorders Drug Treatment Guidelines

Anxiety Disorders Drug Treatment Guidelines Western Australian Psychotropic Drugs Committee Anxiety Disorders Drug Treatment Guidelines August 2008 www.watag.org.au Table of Contents Executive Summary... 4 Psychological or pharmacological treatment?...

More information

4. Central Nervous System

4. Central Nervous System 4. Central Nervous System 1 For further advice on mental health issues see NHS Fife website www.moodcafe.co.uk/ 4.1 - Hypnotics and anxiolytics 4.1.1 Hypnotics Non-drug treatment e.g.sleep hygeine Drug

More information

Psychiatric Medication Information

Psychiatric Medication Information Psychiatric Medication Information A Guide for Patients & Carers 3 rd Edition (November 2013) Revised & Updated St Vincent s Hospital & The University of Melbourne Professor David Castle Chair of Psychiatry

More information

TREATMENT-RESISTANT DEPRESSION AND ANXIETY

TREATMENT-RESISTANT DEPRESSION AND ANXIETY University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2

More information

Dementa Formulary Guidance [v1.0]

Dementa Formulary Guidance [v1.0] Dementa Formulary Guidance [v1.0] 1. Introduction These Guidelines are intended for routine use. However there will be instances where they are not suitable for the patient you are managing, where more

More information

POPULAR DEPRESSION MEDICATIONS

POPULAR DEPRESSION MEDICATIONS Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant

More information

Clinical Audit: Prescribing antipsychotic medication for people with dementia

Clinical Audit: Prescribing antipsychotic medication for people with dementia Clinical Audit: Prescribing antipsychotic medication for people with dementia Trust, team and patient information Q1. Patient's DIS number... Q2. Patient s residence: Home Residential Home Nursing Home

More information

TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10

TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10 AMBO PROJECT: ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10 Belinda Lloyd ambo project: Alcohol and Drug Related Ambulance

More information

Bipolar disorder. Understanding NICE guidance

Bipolar disorder. Understanding NICE guidance Understanding NICE guidance Information for people who use NHS services Bipolar disorder NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments

More information

and body dysmorphic disorder (BDD) in adults, children and young people Issue date: November 2005

and body dysmorphic disorder (BDD) in adults, children and young people Issue date: November 2005 Issue date: November 2005 Treating obsessivecompulsive disorder (OCD) and body dysmorphic disorder (BDD) in adults, children and young people Understanding NICE guidance information for people with OCD

More information

4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA

4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA DEMENTIA Q&A 4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA People with dementia may at some point in their illness develop behavioural or psychological symptoms. While it is

More information

COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014

COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014 COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014 I. GENERAL CONSIDERATIONS A. Definition: Anxiolytic

More information

Medications for bipolar disorder

Medications for bipolar disorder Medications for bipolar disorder Findings from Australian National Survey of Mental Health and Wellbeing (Mitchell et al, 2004) In 12 months, only one-third saw a mental health professional 40% received

More information

Overview of Mental Health Medication Trends

Overview of Mental Health Medication Trends America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription

More information

GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2

GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2 SH CP 29 GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Summary: Guidelines for the use of paliperidone palmitate (Xeplion ) Keywords (minimum of 5): (To assist policy search engine) Target

More information

Depression in adults with a chronic physical health problem

Depression in adults with a chronic physical health problem Depression in adults with a chronic physical health problem Treatment and management Issued: October 2009 NICE clinical guideline 91 guidance.nice.org.uk/cg91 NICE has accredited the process used by the

More information

Handout 2 List of medications used to treat mental illness

Handout 2 List of medications used to treat mental illness Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following

More information

Guidance on the use of stop smoking products

Guidance on the use of stop smoking products Guidance on the use of stop smoking products Ref: Pharm-0000.v6 Status: Ratified Guidance on the use of stop smoking products Page 1 of 15 Approval date Contents 1. Purpose... 4 2. Related documents...

More information

NICE Clinical guideline 23

NICE Clinical guideline 23 NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised

More information

What are the best treatments?

What are the best treatments? What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,

More information

Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care

Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care Issue date: July 2006 Bipolar disorder The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE clinical guideline 38 Developed by the National Collaborating

More information

MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION

MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic

More information

ANXIOLYTICS & HYPNOTICS GUIDELINES TREATMENT OF ANXIETY DISORDERS AND INSOMNIA

ANXIOLYTICS & HYPNOTICS GUIDELINES TREATMENT OF ANXIETY DISORDERS AND INSOMNIA ANXIOLYTICS & HYPNOTICS GUIDELINES TREATMENT OF ANXIETY DISORDERS AND INSOMNIA Edition 7.0 February 2012 Anxiolytics & Hypnotics Guidelines Authors: Mrs Katie Sims Clinical Pharmacist,. Mrs Kiran Hewitt

More information

Psychotherapeutic Medications: What Every Counselor Should Know

Psychotherapeutic Medications: What Every Counselor Should Know Psychotherapeutic Medications: What Every Counselor Should Know Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Antipsychotics/Neuroleptics Antipsychotics,

More information

Medications for Huntington s Disease Vicki Wheelock, M.D.

Medications for Huntington s Disease Vicki Wheelock, M.D. Medications for Huntington s Disease Vicki Wheelock, M.D. Director, HDSA Center of Excellence at UC Davis June 4, 2013 Outline Introduction and disclaimers Medications for cognitive symptoms Medications

More information

If you are not clear about why an antidepressant has been suggested for you, ask your doctor.

If you are not clear about why an antidepressant has been suggested for you, ask your doctor. Antidepressants Aims of the leaflet This leaflet is for anyone who wants to know more about antidepressants. It discusses how they work, why they are prescribed, their effects and side-effects, and alternative

More information

Costing statement: Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults

Costing statement: Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults Costing statement: Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults Introduction The partial update of the guideline on Generalised anxiety disorder and panic disorder

More information

Psychopharmacotherapy for Children and Adolescents

Psychopharmacotherapy for Children and Adolescents TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners

More information

NICE clinical guideline 90

NICE clinical guideline 90 Depression in adults The treatment and management of depression in adults Issued: October 2009 NICE clinical guideline 90 guidance.nice.org.uk/cg90 NHS Evidence has accredited the process used by the Centre

More information

Depression: management of depression in primary and secondary care

Depression: management of depression in primary and secondary care Issue date: December 2004 Quick reference guide Depression: management of depression in primary and secondary care Clinical Guideline 23 Developed by the National Collaborating Centre for Mental Health

More information

How To Treat A Mental Health Condition

How To Treat A Mental Health Condition Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

NHS FORTH VALLEY Drug Treatment of Depression

NHS FORTH VALLEY Drug Treatment of Depression NHS FORTH VALLEY Drug Treatment of Depression Endorsed by: Primary Care Prescribing Group Primary Care Drug and Therapeutics Committee Area Drug and Therapeutics Committee Depression ICP Group Approved

More information

These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.

These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. This is a new guideline. These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. It incorporates NICE clinical

More information

A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES

A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES INTRODUCTION A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES Individuals with intellectual disabilities are not uncommonly prescribed psychotropic medications.

More information

Benzodiazepine & Z drugs withdrawal protocol

Benzodiazepine & Z drugs withdrawal protocol Benzodiazepine & Z drugs withdrawal protocol Rationale The NSF for Older People has highlighted the issues of dependence, sedation and fall in the elderly when taking these types of medications. It has

More information

Early Morning Waking Excessively Orderly or Perfectionistic

Early Morning Waking Excessively Orderly or Perfectionistic COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038

More information

Disclosure Statement. Nursing Facility Regulations and Psychotropic Medication Use. Learning Objectives (Cont) Learning Objectives

Disclosure Statement. Nursing Facility Regulations and Psychotropic Medication Use. Learning Objectives (Cont) Learning Objectives Nursing Facility Regulations and Psychotropic Medication Use Jeffrey C. Reist PharmD, BCPS College of Pharmacy The University of Iowa December 2010 Disclosure Statement I, Jeffrey Reist, PharmD, BCPS do

More information

Only the best medication.

Only the best medication. Only the best medication. Your guide to antipsychotic and mood stabiliser medication 1 Contents 4. Introduction 6. 6 step guide to finding the right medication for you 8. Step 1 finding the right medication

More information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency

More information

Mental Health Medications

Mental Health Medications Mental Health Medications National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Contents Mental Health Medications..............................................................1

More information

Medications Used in the Management of Disruptive Behavior Disorders

Medications Used in the Management of Disruptive Behavior Disorders The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.

More information

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage withdrawal during detoxification, stabilisation and substitution as well as for relapse prevention,

More information

Medications A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications.

Medications A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications. A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications. 2014 Contents Introduction: Mental Health Medications...1 What are

More information

BENZODIAZEPINE PRESCRIBING SUPPORT PACK

BENZODIAZEPINE PRESCRIBING SUPPORT PACK BENZODIAZEPINE PRESCRIBING SUPPORT PACK Background Prescribing of benzodiazepine drugs is widespread but dependence (both physical and psychological) and tolerance occur. This may lead to difficulty in

More information

MVP s Medicare Stars Ratings: High Risk Medications

MVP s Medicare Stars Ratings: High Risk Medications MVP s Medicare Stars Ratings: High Risk Medications The Center for Medicare and Medicaid Services (CMS) uses the Star Rating System to evaluate Medicare Advantage health plans as well as their networks

More information

A GUIDE TO THE MANAGEMENT OF PSYCHOTIC DISORDERS AND NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN OLDER ADULTS From THE AMERICAN GERIATRICS SOCIETY

A GUIDE TO THE MANAGEMENT OF PSYCHOTIC DISORDERS AND NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN OLDER ADULTS From THE AMERICAN GERIATRICS SOCIETY A GUIDE TO THE MANAGEMENT OF PSYCHOTIC DISORDERS AND NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN OLDER ADULTS From THE AMERICAN GERIATRICS SOCIETY ThisguidewasreviewedbyapanelofAGSmembersrepresentinggeriatricmedicine,geropsychiatry,andgeriatricpharmacy.The

More information

Depression Pathway. Patient Education Box 4. Guided self help Box 18. pg 11

Depression Pathway. Patient Education Box 4. Guided self help Box 18. pg 11 LCFT localised Map pathway June 2009 Depression Pathway Instructions: Throughout this pathway if you click on the Bookmarks tab to the left of the screen and then click on the various documents you will

More information

Psychiatric medications

Psychiatric medications helping families & friends find better ways Psychiatric medications Introduction The experience of mental illness can have a profound impact upon people s work, family and social lives, as well as on confidence

More information

Psychotropic Medication in Pregnancy/Lactation. Mercy Hospital for Women. 2nd Edition. www.mercy.com.au

Psychotropic Medication in Pregnancy/Lactation. Mercy Hospital for Women. 2nd Edition. www.mercy.com.au Psychotropic Medication in Pregnancy/ 2nd Edition www.mercy.com.au Mercy Hospital for Women Psychotropic Medication in Pregnancy/ 2nd Edition General Points: None of the Psychotropic medications have been

More information

Antipsychotics and the Nursing Home

Antipsychotics and the Nursing Home Antipsychotics and the Nursing Home Lisa M. O Hara, PharmD, CGP Corporate Director of Clinical Services The State Operations Manual Part 1: F329 Unnecessary Drugs Medication Management Defined Helps promote

More information

New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine

New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept

More information

The pharmacological management of anxiety disorders

The pharmacological management of anxiety disorders Anxiety s z Review The pharmacological management of anxiety s Stephen Bleakley MRPharmS, MSc, FCMHP, Simon JC Davies DM (Oxon), MBBS (Lond), MRCPsych, MSc (LSHTM), MSc (Maastricht/Florence) Progress in

More information

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include: Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic

More information

Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,

More information

Managing Patients with Pain, Psychiatric Co-Morbidity & Addiction

Managing Patients with Pain, Psychiatric Co-Morbidity & Addiction Managing Patients with Pain, Psychiatric Co-Morbidity & Addiction John A. Renner Jr., MD, CAS Division of Psychiatry Boston University School of Medicine Prescribers Clinical Support System for Opioid

More information

Trends in Prescribing of Antipsychotic Drugs in General Practice in England (Chart 1) 2.0. Other second generation antipsychotics (SGA)

Trends in Prescribing of Antipsychotic Drugs in General Practice in England (Chart 1) 2.0. Other second generation antipsychotics (SGA) Antipsychotic drugs Antipsychotics can be broadly classified into first generation antipsychotics (FGAs, formerly known as typical antipsychotics) and second generation antipsychotics (SGAs, formerly known

More information

The management of bipolar disorder in adults, children and adolescents, in primary and secondary care

The management of bipolar disorder in adults, children and adolescents, in primary and secondary care Quick reference guide Issue date: July 2006 Bipolar disorder The management of bipolar disorder in adults, children and adolescents, in primary and secondary care Developed by the National Collaborating

More information

Bipolar disorder. Australian treatment guide for consumers and carers

Bipolar disorder. Australian treatment guide for consumers and carers August 2009 Bipolar disorder Australian treatment guide for consumers and carers Contents The Royal Australian and New Zealand College of Psychiatrists, 2009 Compiled by The Royal Australian and New Zealand

More information

Amendments to recommendations concerning venlafaxine

Amendments to recommendations concerning venlafaxine Amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine*. This amendment brings the guideline into line with the new advice but does

More information

CLINICIAN INTERVIEW COMPLEXITIES OF BIPOLAR DISORDER. Interview with Charles B. Nemeroff, MD, PhD

CLINICIAN INTERVIEW COMPLEXITIES OF BIPOLAR DISORDER. Interview with Charles B. Nemeroff, MD, PhD COMPLEXITIES OF BIPOLAR DISORDER Interview with Charles B. Nemeroff, MD, PhD Dr Nemeroff is the Reunette W. Harris Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Emory

More information

Pharmacological Management of Dementia

Pharmacological Management of Dementia Pharmacological Management of Dementia Christopher Sullivan Lead Clinical Pharmacist South and West Devon Devon Partnership Trust Overview Management of cognitive symptoms Management of non-cognitive symptoms

More information

Recognition and Treatment of Depression in Parkinson s Disease

Recognition and Treatment of Depression in Parkinson s Disease Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,

More information

ATYPICALS ANTIPSYCHOTIC MEDICATIONS

ATYPICALS ANTIPSYCHOTIC MEDICATIONS The atypical antipsychotics are a class of drugs that are used to treat a number of behavioral health disorders, including schizophrenia, other psychotic disorders, mood disorders, and behavioral agitation

More information

Major Depression. What is major depression?

Major Depression. What is major depression? Major Depression What is major depression? Major depression is a serious medical illness affecting 9.9 million American adults, or approximately 5 percent of the adult population in a given year. Unlike

More information

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM 3 rd Quarter 2015 BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM Introduction Benzodiazepines, sometimes called "benzos",

More information

Member Rights & Responsibilities

Member Rights & Responsibilities Member Rights & Responsibilities Member Rights and Responsibilities Blue KC has updated our Member Rights & Responsibilities to be consistent across all of our HMO and PPO products. Blue KC members have:

More information

IMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below:

IMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below: Case Number: CM13-0018009 Date Assigned: 10/11/2013 Date of Injury: 06/11/2004 Decision Date: 01/13/2014 UR Denial Date: 08/16/2013 Priority: Standard Application Received: 08/29/2013 HOW THE IMR FINAL

More information

A few general principles regarding medications are important to consider before initiating therapy in individuals diagnosed with a dementia

A few general principles regarding medications are important to consider before initiating therapy in individuals diagnosed with a dementia MEDICATIONS USED FOR THE MANAGEMENT OF DEMENTIA AND RELATED BEHAVIORIAL COMPLICATIONS* R.Ron Finley, B.S Pharm, R.Ph,CGP, Aimee Loucks, Pharm. D., Gil D. Rabinovici, M.D The following is intended to be

More information

Depression. Depress EPRESSION. Depression

Depression. Depress EPRESSION. Depression Depress EPRESSION Depression Depression DEPRESSION Most people feel depressed at times. Losing a loved one, getting fired from a job, going through a divorce, and other difficult situations can lead a

More information

Depression. The treatment and management of depression in adults. This is a partial update of NICE clinical guideline 23

Depression. The treatment and management of depression in adults. This is a partial update of NICE clinical guideline 23 Issue date: October 2009 Depression The treatment and management of depression in adults This is a partial update of NICE clinical guideline 23 NICE clinical guideline 90 Developed by the National Collaborating

More information

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations

More information

Conjoint Professor Brian Draper

Conjoint Professor Brian Draper Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course

More information

TTTF2- Project ECHO Selecting the Optimal Tobacco Cessation Medication Rosario Wippold

TTTF2- Project ECHO Selecting the Optimal Tobacco Cessation Medication Rosario Wippold TTTF2- Project ECHO Selecting the Optimal Tobacco Cessation Medication Rosario Wippold Selecting the Optimal Tobacco Cessation Medication Review medical/ mental health conditions to have into account when

More information

TREATING MAJOR DEPRESSIVE DISORDER

TREATING MAJOR DEPRESSIVE DISORDER TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.

More information

1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care

1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When

More information

Step 2: Recognised depression in adults persistent subthreshold depressive symptoms or mild to moderate depression

Step 2: Recognised depression in adults persistent subthreshold depressive symptoms or mild to moderate depression Step 2: Recognised depression in adults persistent subthreshold depressive symptoms or mild to moderate depression A NICE pathway brings together all NICE guidance, quality standards and materials to support

More information

Mental Health & Substance Use Disorders

Mental Health & Substance Use Disorders Mental Health & Substance Use Disorders Thank you to Daniella Kanareck Dr. Arielle Taylor Overview 1. Overview of Mental Health 2. Stigma and attitudes associated with this population 3. Mental Disorders

More information

APPROVAL OF NEW NERVOUS SYSTEM DRUGS IN INDIA COMPARED WITH THE US AND EU

APPROVAL OF NEW NERVOUS SYSTEM DRUGS IN INDIA COMPARED WITH THE US AND EU Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Suppl 4, 2012 Research Article APPROVAL OF NEW NERVOUS SYSTEM DRUGS IN INDIA COMPARED WITH THE US

More information

Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD)

Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD) Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD) Overview of Prescription The DD/MR patient may develop symptoms

More information

Unipolar Depression Management Protocol

Unipolar Depression Management Protocol Unipolar Depression Management Protocol All Team Members: Patient Self-Management Education & Support Unipolar depression or Major Depressive Disorder means that the patient feels persistent low mood or

More information

Post-traumatic stress disorder (PTSD): the treatment of PTSD in adults and children

Post-traumatic stress disorder (PTSD): the treatment of PTSD in adults and children Post-traumatic stress disorder (PTSD): the treatment of PTSD in adults and children Understanding NICE guidance information for people with PTSD, their advocates and carers, and the public March 2005 Information

More information

1. According to recent US national estimates, which of the following substances is associated

1. According to recent US national estimates, which of the following substances is associated 1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates

More information

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological

More information

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),

More information

Depression. Medicines To Help You

Depression. Medicines To Help You Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available

More information

Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence

Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.

More information

Shared Care Protocol for Atypical Antipsychotics

Shared Care Protocol for Atypical Antipsychotics Shared Care Protocol for Atypical Antipsychotics Version Number: 2 Name of originator/author: Chief Pharmacist, 07813 783165 (with thanks to GMW) Name of responsible committee: Clinical Governance Committee

More information

DRUG DRIVING OFFENCES

DRUG DRIVING OFFENCES DRUG DRIVING OFFENCES Taking drug can affect body and mind coordination that can significantly impair the ability to drive a motor vehicle. Road Traffic Ordinance (Cap 374) was amended in 2011 in order

More information

Post-traumatic stress disorder overview

Post-traumatic stress disorder overview Post-traumatic stress disorder overview A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive

More information